Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
10.01
-0.18 (-1.77%)
Nov 19, 2026, 4:00 PM EST - Market closed
Corvus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $27 | Buy | Maintains | $27 | +169.73% | Nov 11, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $33 | Buy | Reiterates | $33 | +229.67% | Nov 6, 2026 |
| Barclays | Barclays | Buy Maintains $28 | Buy | Maintains | $28 | +179.72% | Nov 6, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $30 → $27 | Buy | Maintains | $30 → $27 | +169.73% | Oct 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $40 | Buy | Maintains | $40 | +299.60% | May 15, 2026 |
| Jefferies | Jefferies | Buy Maintains $13 → $42 | Buy | Maintains | $13 → $42 | +319.58% | Jan 22, 2026 |